What is the difference between Semaglutide and Tirzepatide?

The main difference is mechanism and research stage. Semaglutide targets GLP-1 (mono agonist) (approved formulations exist) and is studied for metabolic & body-weight research; Tirzepatide targets GLP-1 + GIP (dual agonist) (approved formulations exist) and is studied for metabolic & body-weight research. Both are research-use-only compounds, not for human or animal use.

Are Semaglutide and Tirzepatide approved for human use?

No. Renova Wellness supplies both strictly for in-vitro laboratory and scientific research use only. Research status differs — Semaglutide: approved formulations exist; Tirzepatide: approved formulations exist — but neither is sold for human or animal consumption, and no medical, therapeutic, or dosing claims are made.

How is purity verified for Semaglutide and Tirzepatide?

Every lot of both compounds ships with its own per-batch Certificate of Analysis — identity by mass spectrometry, ≥98% purity by HPLC, and a unique lot number you can verify against the vial in your hand.

Research Comparison

Semaglutide vs Tirzepatide

Semaglutide and Tirzepatide are often compared because both sit in metabolic research. Semaglutide acts on GLP-1 (mono agonist) and is studied for metabolic & body-weight research, while Tirzepatide acts on GLP-1 + GIP (dual agonist) and is studied for metabolic & body-weight research. Both are supplied as lyophilized powder for in-vitro laboratory research only — this page compares mechanism and research status, not dosing or human use.

Semaglutide

Metabolic

Tirzepatide

Metabolic

Frequently asked

What is the difference between Semaglutide and Tirzepatide?: The main difference is mechanism and research stage. Semaglutide targets GLP-1 (mono agonist) (approved formulations exist) and is studied for metabolic & body-weight research; Tirzepatide targets GLP-1 + GIP (dual agonist) (approved formulations exist) and is studied for metabolic & body-weight research. Both are research-use-only compounds, not for human or animal use.
Are Semaglutide and Tirzepatide approved for human use?: No. Renova Wellness supplies both strictly for in-vitro laboratory and scientific research use only. Research status differs — Semaglutide: approved formulations exist; Tirzepatide: approved formulations exist — but neither is sold for human or animal consumption, and no medical, therapeutic, or dosing claims are made.
How is purity verified for Semaglutide and Tirzepatide?: Every lot of both compounds ships with its own per-batch Certificate of Analysis — identity by mass spectrometry, ≥98% purity by HPLC, and a unique lot number you can verify against the vial in your hand.

Related comparisons

Retatrutide (GLP-3) vs Semaglutide Retatrutide (GLP-3) vs Tirzepatide

Build a multi-compound set in the Stack Builder or run the reconstitution calculator.

Research references

Primary literature for Semaglutide and Tirzepatide. Provided for scientific context only — not medical or dosing guidance.

Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021. PMID 33567185 →
Amaro A, et al. Cardiometabolic risk factors efficacy of semaglutide in the STEP program. Postgrad Med. 2022. PMID 36691308 →
Min T, Bain SC. The Role of Tirzepatide, Dual GIP and GLP-1 Receptor Agonist, in the Management of Type 2 Diabetes: The SURPASS Clinical Trials. Diabetes Ther. 2021. PMID 33325008 →
Karagiannis T, et al. Management of type 2 diabetes with the dual GIP/GLP-1 receptor agonist tirzepatide: a systematic review and meta-analysis. Diabetologia. 2022. PMID 35579691 →

Research use only. This comparison covers mechanism, target, and research status. It is not medical, therapeutic, or dosing advice. Compounds sold by Renova Wellness™ are for in-vitro laboratory research and are not for human or animal consumption.